Ono Pharmaceutical Co (Ono Pharmaceutical Co) Short-Term Capital Lease Obligation : $15 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Ono Pharmaceutical Co Short-Term Capital Lease Obligation?

Ono Pharmaceutical Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $15 Mil.

Ono Pharmaceutical Co's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 ($16 Mil) to Dec. 2023 ($16 Mil) and declined from Dec. 2023 ($16 Mil) to Mar. 2024 ($15 Mil).

Ono Pharmaceutical Co's annual Short-Term Capital Lease Obligation declined from Mar. 2022 ($19 Mil) to Mar. 2023 ($19 Mil) and declined from Mar. 2023 ($19 Mil) to Mar. 2024 ($15 Mil).

Ono Pharmaceutical Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Ono Pharmaceutical Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Short-Term Capital Lease Obligation Chart

Ono Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

20.32

18.61

19.41

18.63

15.42

Ono Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															18.63	17.21	15.81	15.74	15.42

Ono Pharmaceutical Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Ono Pharmaceutical Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLY) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

OPHLF:USA 4528:Japan ON4:Germany

Address

8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564

Website

http://www.ono.co.jp

Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Headlines

From GuruFocus

T. Rowe Price Japan Fund Purchases 5 Stocks in 3rd Quarter

By Holly LaFon Holly LaFon • 10-18-2017

Samuel Isaly's Eaton Vance Worldwide Health Sciences Fund Q1 Investment Report

By Holly LaFon Holly LaFon • 05-13-2016

Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million

By PRNewswire • 12-01-2023

Ono Pharmaceutical Co Stock Appears To Be Modestly Undervalued

By GF Value • 07-05-2021